Wordt geladen...
Ipilimumab and Pembrolizumab Mixed Response in a 41-Year-Old Patient with SMARCA4-Deficient Thoracic Sarcoma: An Interdisciplinary Case Study
SMARCA4-deficient thoracic sarcoma is a newly described entity of thoracic sarcomas with a poor prognosis, defined by poorly differentiated epithelioid to rhabdoid histomorphology and SMARCA4 gene inactivation. We present a case of a SMARCA4-deficient thoracic sarcoma in a 41-year-old male with a sm...
Bewaard in:
| Gepubliceerd in: | Case Rep Oncol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
S. Karger AG
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8215992/ https://ncbi.nlm.nih.gov/pubmed/34177520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000515416 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|